04 December 2025 : Clinical Research
Early Postpartum IL-10 and IL-37 Concentrations in Women with Gestational Diabetes Mellitus
Kamila GorczycaDOI: 10.12659/MSM.949081
Med Sci Monit 2025; 31:e949081
Table 2 Descriptive characteristics and comparison of GDM and control groups by pregnancy and delivery-related variables.
| Variable | Control Group [n=50] | GDM Group [n=30] | P |
|---|---|---|---|
| n (%) or Median [IQR] | |||
| 0.0174c | |||
| 1 | 15 (30%) | 17 (56.7%) | |
| 2 | 20 (40%) | 9 (30%) | |
| 3 | 8 (16%) | 1 (3.3%) | |
| 4 | 7 (14%) | 1 (3.3%) | |
| 5 | 0 (0%) | 2 (6.7%) | |
| 0.0218c | |||
| 1 | 15 (30%) | 18 (60%) | |
| 2 | 20 (40%) | 9 (30%) | |
| 3 | 8 (16%) | 0 (0%) | |
| 4 | 7 (14%) | 3 (10%) | |
| 39 [–]37 | 39 [35.5–40] | 0.0516a | |
| 0.0021b | |||
| Vaginal | 44 (88%) | 16 (53.3%) | |
| Cesarean section | 6 (12%) | 14 (46.7%) | |
| 0.0028c | |||
| 2–5 | 1 (2%) | 1 (3.3)% | |
| 5–10 | 13 (26.%) | 14 (46.7%) | |
| 10–15 | 20 (40%) | 7 (23.3%) | |
| 15–20 | 16 (32%) | 3 (10%) | |
| 20–25 | 0 (0%) | 5 (16.7%) | |
| * Statistically significant result; a Mann-Whitney U test; b Fisher’s exact test; c Chi-square test. GDM – gestational diabetes mellitus; IQR – interquartile range. | |||






